Stephanie Richards is an associate in the firm’s Business Law Department and a member of its Technology Companies and Life Sciences group.

Ms. Richards represents public and private life sciences and technology companies as well as private equity funds and investment banks across the life sciences and technology industries. She counsels clients on a wide array of corporate matters, including public and private securities offerings, mergers and acquisitions, securities law compliance, and strategic transactions. She has experience advising companies through every stage of the corporate life cycle from initial financing through successful initial public offering or acquisition. She joined Goodwin in 2018.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Ms. Richards’ transactional experience includes the following capital markets transactions and mergers and acquisitions:

Capital Markets

  • Xeris Pharmaceuticals in its initial public offering on the Nasdaq Global Market and subsequent follow-on offering
  • TCR2 Therapeutics in its initial public offering on the Nasdaq Global Market
  • The underwriters in Tufin Software Technologies’ initial public offering on the New York Stock Exchange
  • Celyad in a global offering on the Nasdaq Global Market
  • The underwriters in several follow-on offerings by Viking Therapeutics on the Nasdaq Global Market

Mergers and Acquisitions

  • ProKidney and its lead investor, Pablo Legorreta, founder and CEO of Royalty Pharma, in the acquisition of inRegen and Twin City Bio, LLC
  • Adhaere Pharmaceuticals in its sale to Gossamer Bio
  • 2U in its acquisition of CritiqueIt

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D./LL.M., 2013
Duke University School of Law
B.A., English, 2010
Yale College

Admissions

Bar

Massachusetts
California
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师